What Will Boris Mean for the Markets?

Guy Foster, Group Head of Research at Brewin Dolphin, comments on the appointment of Boris Johnson as Prime Minister. He explores the likely next steps for Boris, the impact that his appointment will have on Brexit negotiations and predicts how this will affect the economy. 

Key points include:

  • Boris Johnson’s appointment as PM makes a no-deal Brexit seem like a closer prospect than ever – but Brewin Dolphin still think it unlikely to occur
  • Johnson’s rhetoric leaves room for both the UK Government and EU to make concessions that could result in a deal
  • While Brewin Dolphin think it unlikely to happen, if there is a no-deal Brexit UK Government, bond prices would be expected to rally 
  • The pound would likely fall, benefiting the large internationally-focused companies that dominate the FTSE 100




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

The Inspiring Leaders Podcast...

Exploring the landscape for businesses in 2024, this episode is part of Criticaleye's Inspiring Leaders Podcast series. Featuring Criticaleye Host and Director of Content, Marc Barber, and special guest Matthew Blag...

Click here to download this insight
Global Economic Outlook 2024

Criticaleye Senior Editors ask Members of its global Community for their predictions on how various economies will fare over 2024, along with other key macroeconomic developments that will impact business decisions. ...

Click here to download this insight
CFO Research Results 2024

This research, conducted at our CFO Retreat, subtitled New Models for Growth, provides a fascinating insight into the challenges and priorities for CFOs this year. Key findings from Criticaleye's CFO Research:&nb...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 652




London Stock Exchange Redwood Bank Concentrix + Webhelp Legal & General Investment Management Veolia Water Technologies AlixPartners Amazon UK Google Salesforce Accenture LDC Tullow Oil plc Drax Group plc Workday Lightsource bp E.ON UK GlaxoSmithKline plc NATS Robert Walters Mayborn Group Eightfold AI Royal London Group Eton Bridge Partners Bunzl plc